If you need any further evidence of just how much the COVID-19 pandemic has increased the allure of biotechnology stocks, consider the little-known Chinese biotech company that saw such an influx of interest upon its recent trading debut that demand for shares exceeded the number of shares on offer by hundreds of times! For more on this particular biotech company — and how the high levels of interest in biotech could make it the “next gold mine” – CLICK HERE.